←
Combinostics263 posts
Combinostics avatar

Combinostics

@combinostics

Using a combination of science and innovative AI technology, we aim to make a difference in the lives of patients with neurological disorders.

◷ Joined March 2018▧ 187 Photos and videos
Combinostics avatar
Combinostics@combinostics·18 Jul 2023

Attention #aaic2023 attendees, join us today as Combinostics CEO Lennart Thurfjell and Professor Linus Jönsson from Karolinska Institutet, delve into the intriguing topic of "The role of software tools and AI in the context of new disease modifying drugs in AD.

Post attachment
Combinostics avatar
Combinostics@combinostics·16 Jul 2023

🌟 Exciting times at AAIC 2023! Our team is having a great first day showcasing Combinostics' imaging and decision support solutions for Dementia care. Don't miss your chance to learn more at booth 414!

Post attachmentPost attachment
Combinostics avatar
Combinostics@combinostics·11 Jul 2023

1 week to go until Combinostics CEO, Lennart Thurfjell, and Professor Linus Jönsson from Karolinska Institutet delve into the role of AI in the context of new disease-modifying drugs for Alzheimer's Disease at #aaic2023. Join them on July 18th, from 12:30 – 1:15.

Post attachment
Combinostics avatar
Combinostics@combinostics·27 Jun 2023

Can you believe it's already the last day of #snmmi2023? We've had an amazing time in Chicago discussing the latest in #fdgpet and #amyloidpet quantification. If you haven't stopped by booth 3016 yet, now is your last chance to join the conversation. See you there!

Post attachmentPost attachment
Combinostics avatar
Combinostics@combinostics·25 May 2023

Here, researchers, including our medical advisor, @FBarkhof, found that amyloid PET early in a diagnostic workup supported an etiological diagnosis with very high confidence after only 3 months, indicating its usefulness in clinical practice. eu1.hubs.ly/H03Vs-20

Combinostics avatar
Combinostics@combinostics·23 May 2023

More exciting news: The Phase 3 trial of donanemab met its primary endpoint and all secondary endpoints, showing promise for its ability to slow cognitive and functional decline in people with early symptomatic Alzheimer's disease. eu1.hubs.ly/H03SYSn0

Combinostics avatar
Combinostics@combinostics·18 May 2023

Are you at #röko2023 today? Don't miss the Combinostics Presentation from Elena Bonke! Supporting the entire patient pathway: Early detection, diagnosis, and ongoing management of Alzheimer’s disease and other major neurological disorders 2:45 – 3:00 pm See you there!

Post attachment
Combinostics avatar
Combinostics@combinostics·12 May 2023

Welcome to our new Clinical Application Specialist in Europe – Elena Bonke. Elena is passionate about pioneering breakthroughs in healthcare by bridging the gap between clinical application and technical advancements. Happy to have you on board!

Post attachment